BI-1808 and pembrolizumab combination shows a 24% ORR in recurrent ovarian cancer, surpassing pembrolizumab monotherapy's 8% ...

Dr. Maik Luu discusses how postbiotics can be used to reprogram CAR T cells to promote anti-tumor function and what further ...

The field of cancer research has increasingly focused on the metabolic underpinnings of tumorigenesis, recognizing how the reprogramming of cellular energy ...

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against ...

Pancreatic ductal adenocarcinoma is one of the deadliest cancers due to its late detection, dense tumour structure, and resistance to conventional therapies.

FAYETTEVILLE, GA, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- Understanding why cancer cells rely on specific ...

So if PPARγ is pushing a cell toward becoming a fat cell, YAP and TAZ can override that instruction and keep the cell in a ...

Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body.

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers.

Ageing is often described as a slow accumulation of damage, but a new study suggests something more subtle may be happening ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...